DiSignAtlas

Identifying the complex molecular changes underlying diverse diseases remains a grand challenge in biomedicine. While high-throughput omics technologies have enabled unbiased interrogation of disease perturbations, making sense of the data deluge to pinpoint key drivers and biomarkers is no trivial task. This is where disease molecular signatures come in – sets of genes, proteins, or…